Management of Sexually Transmitted Diseases in HIV-Infected Men and Women

  • Author: Jeanne Marrazzo, MD, MPH, FACP, FIDSA (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/8/18 (What's New)

Summary

  • The quadrivalent human papillomavirus vaccine confers protection against HPV types 6/11 (responsible for 90% of genital warts) and 16/18 (responsible for 70% of cervical cancers)[Markowitz 2007]
    • The quadrivalent vaccine is also approved by the FDA for prevention of anal cancer and associated precancerous lesions in persons infected with these HPV types[FDA 2010]
  • The 9-valent human papillomavirus vaccine confers protection against HPV subtypes 6, 11, 16, 18, 31, 33, 45, 52, and 58

    Action required